102 related articles for article (PubMed ID: 11061028)
1. Reversible binding of heparin to the loop peptide of endotoxin neutralizing protein.
Ridge RJ; Paus EJ; Novitsky TJ; Ketchum PA
J Endotoxin Res; 2000; 6(1):17-23. PubMed ID: 11061028
[TBL] [Abstract][Full Text] [Related]
2. Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide.
Andrä J; Garidel P; Majerle A; Jerala R; Ridge R; Paus E; Novitsky T; Koch MH; Brandenburg K
Eur J Biochem; 2004 May; 271(10):2037-46. PubMed ID: 15128313
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide detoxification by endotoxin neutralizing protein.
Fletcher MA; McKenna TM; Quance JL; Wainwright NR; Williams TJ
J Surg Res; 1993 Aug; 55(2):147-54. PubMed ID: 8412093
[TBL] [Abstract][Full Text] [Related]
4. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor.
Ried C; Wahl C; Miethke T; Wellnhofer G; Landgraf C; Schneider-Mergener J; Hoess A
J Biol Chem; 1996 Nov; 271(45):28120-7. PubMed ID: 8910426
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution.
Hoess A; Watson S; Siber GR; Liddington R
EMBO J; 1993 Sep; 12(9):3351-6. PubMed ID: 8253062
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor.
Kloczewiak M; Black KM; Loiselle P; Cavaillon JM; Wainwright N; Warren HS
J Infect Dis; 1994 Dec; 170(6):1490-7. PubMed ID: 7995989
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
[TBL] [Abstract][Full Text] [Related]
8. Identification of the LPS-binding domain of an endotoxin neutralising protein, Limulus anti-LPS factor.
Hoess A; Schneider-Mergener J; Liddington RC
Prog Clin Biol Res; 1995; 392():327-37. PubMed ID: 8524938
[No Abstract] [Full Text] [Related]
9. Heparin binding properties of the carboxyl terminal domain of [A103,106,108] antistasin 93-119.
Manley GD; Owen TJ; Krstenansky JL; Brankamp RG; Cardin AD
Adv Exp Med Biol; 1992; 313():135-40. PubMed ID: 1359737
[TBL] [Abstract][Full Text] [Related]
10. Production of recombinant endotoxin neutralizing protein in Pichia pastoris and methods for its purification.
Paus EJ; Willey J; Ridge RJ; Legg CR; Finkelman MA; Novitsky TJ; Ketchum PA
Protein Expr Purif; 2002 Nov; 26(2):202-10. PubMed ID: 12406673
[TBL] [Abstract][Full Text] [Related]
11. NMR structure of rALF-Pm3, an anti-lipopolysaccharide factor from shrimp: model of the possible lipid A-binding site.
Yang Y; Boze H; Chemardin P; Padilla A; Moulin G; Tassanakajon A; Pugnière M; Roquet F; Destoumieux-Garzón D; Gueguen Y; Bachère E; Aumelas A
Biopolymers; 2009 Mar; 91(3):207-20. PubMed ID: 19107926
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical and biological characterization of anti-endotoxin peptides and their influence on lipid properties.
Kowalski I; Kaconis Y; Andrä J; Razquin-Olazarán I; Gutsmann T; Martinez de Tejada G; Brandenburg K
Protein Pept Lett; 2010 Nov; 17(11):1328-33. PubMed ID: 20673224
[TBL] [Abstract][Full Text] [Related]
13. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor.
Leslie DB; Vietzen PS; Lazaron V; Wasiluk KR; Dunn DL
Surg Infect (Larchmt); 2006 Feb; 7(1):45-52. PubMed ID: 16509785
[TBL] [Abstract][Full Text] [Related]
14. Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70-kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes.
Dziarski R; Gupta D
J Biol Chem; 1994 Jan; 269(3):2100-10. PubMed ID: 8294463
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis.
Andrä J; Howe J; Garidel P; Rössle M; Richter W; Leiva-León J; Moriyon I; Bartels R; Gutsmann T; Brandenburg K
Biochem J; 2007 Sep; 406(2):297-307. PubMed ID: 17501719
[TBL] [Abstract][Full Text] [Related]
16. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
[TBL] [Abstract][Full Text] [Related]
17. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.
Warren HS; Glennon ML; Wainwright N; Amato SF; Black KM; Kirsch SJ; Riveau GR; Whyte RI; Zapol WM; Novitsky TJ
Infect Immun; 1992 Jun; 60(6):2506-13. PubMed ID: 1587618
[TBL] [Abstract][Full Text] [Related]
18. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
[TBL] [Abstract][Full Text] [Related]
19. Primary structure of anti-lipopolysaccharide factor from American horseshoe crab, Limulus polyphemus.
Muta T; Miyata T; Tokunaga F; Nakamura T; Iwanaga S
J Biochem; 1987 Jun; 101(6):1321-30. PubMed ID: 3667549
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.
Kuppermann N; Nelson DS; Saladino RA; Thompson CM; Sattler F; Novitsky TJ; Fleisher GR; Siber GR
J Infect Dis; 1994 Sep; 170(3):630-5. PubMed ID: 8077721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
